<i>EP</i>: CDK4/6i in EBC
ExpressPoints
CDK4/6 Inhibitors in Early-Stage HR+/HER2- Breast Cancer: Individualizing Therapeutic Decisions to Improve Patient Outcomes

Released: July 09, 2021

Javier Cortes
Javier Cortes, MD, PhD
Stephen R. D. Johnston
Stephen R. D. Johnston, MA, FRCP, PhD
Sara M. Tolaney
Sara M. Tolaney, MD, MPH

Activity

Progress
1
Course Completed